We are live on ! Find out more
WRM

Weybosset Research & Management Portfolio holdings

AUM $381M
1-Year Est. Return 42.16%
This Fund
S&P 500
This Quarter Est. Return
-12.98%
1 Year Est. Return
+42.16%
3 Year Est. Return
+73.45%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$147M
AUM Growth
-$27M
Cap. Flow
-$3.28M
Cap. Flow %
-2.24%
Top 10 Hldgs %
53.68%
Holding
57
New
2
Increased
16
Reduced
29
Closed
5

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$413K
2
WELL icon
Welltower
WELL
+$197K
3
COF icon
Capital One
COF
+$71.9K
4
FMC icon
FMC
FMC
+$67.7K
5
NOK icon
Nokia
NOK
+$63.8K

Top Sells

Rank Stock Value
1
INGR icon
Ingredion
INGR
+$930K
2
PII icon
Polaris
PII
+$492K
3
APTV icon
Aptiv
APTV
+$421K
4
SLB icon
SLB Ltd
SLB
+$332K
5
AMZN icon
Amazon
AMZN
+$224K

Sector Composition

Rank Sector Weight
1 Industrials 31.77%
2 Financials 15.79%
3 Technology 12.42%
4 Healthcare 11.06%
5 Consumer Discretionary 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRK.A icon
26
Berkshire Hathaway Class A
BRK.A
$1.1T
$612K 0.42%
2
– –
AAPL icon
27
Apple
AAPL
$4.46T
$592K 0.4%
15,016
-3,912
-21% -$190K
PFE icon
28
Pfizer
PFE
$143B
$545K 0.37%
13,172
-316
-2% -$13.1K
UNP icon
29
Union Pacific
UNP
$173B
$514K 0.35%
3,715
-1,410
-28% -$209K
CSCO icon
30
Cisco
CSCO
$457B
$467K 0.32%
10,775
-1,700
-14% -$77.8K
MCD icon
31
McDonald's
MCD
$188B
$466K 0.32%
2,622
-109
-4% -$19.3K
WELL icon
32
Welltower
WELL
$168B
$462K 0.32%
6,650
+2,900
+77% +$197K
ABBV icon
33
AbbVie
ABBV
$433B
$433K 0.3%
+4,700
New +$413K
DD icon
34
DuPont de Nemours
DD
$19.1B
$430K 0.29%
3,178
-178
-5% -$25.6K
MMM icon
35
3M
MMM
$91.4B
$429K 0.29%
2,691
-239
-8% -$39.7K
AMZN icon
36
Amazon
AMZN
$3.06T
$410K 0.28%
5,460
-2,700
-33% -$224K
MSFT icon
37
Microsoft
MSFT
$3.62T
$383K 0.26%
3,773
-870
-19% -$93.2K
RTX icon
38
RTX Corp
RTX
$292B
$380K 0.26%
5,670
-476
-8% -$37.3K
ARCC icon
39
Ares Capital
ARCC
$13.8B
$378K 0.26%
24,242
+13
+0.1% +$215
V icon
40
Visa
V
$683B
$375K 0.26%
2,843
+100
+4% +$13.8K
JPM icon
41
JPMorgan Chase
JPM
$937B
$343K 0.23%
3,515
– –
ABT icon
42
Abbott
ABT
$185B
$333K 0.23%
4,600
+100
+2% +$7.03K
AMGN icon
43
Amgen
AMGN
$204B
$326K 0.22%
1,675
-50
-3% -$9.76K
ITW icon
44
Illinois Tool Works
ITW
$83B
$320K 0.22%
2,525
-200
-7% -$26.3K
UPS icon
45
United Parcel Service
UPS
$90.8B
$312K 0.21%
3,200
– –
RTN
46
DELISTED
Raytheon Company
RTN
$307K 0.21%
2,000
-100
-5% -$17.9K
CAT icon
47
Caterpillar
CAT
$382B
$299K 0.2%
2,355
-350
-13% -$45.5K
ACN icon
48
Accenture
ACN
$101B
$282K 0.19%
2,000
+50
+3% +$7.91K
VFC icon
49
VF Corp
VFC
$5.87B
$221K 0.15%
3,292
– –
NOK icon
50
Nokia
NOK
$52.3B
$66K 0.05%
+11,365
New +$63.8K
1
2
3

Similar funds

HCP
Hiddenite Capital Partners New York $381M AUM 73.07% 1-Year Est. Return
CIC
Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return
SFWC
Strategic Family Wealth Counselors Fairfield, New Jersey $381M AUM 21.36% 1-Year Est. Return
AWA
Aquire Wealth Advisors South Jordan, Utah $381M AUM 17.5% 1-Year Est. Return
MC
Muhlenkamp & Co Wexford, Pennsylvania $380M AUM 43.74% 1-Year Est. Return
STP
Science & Technology Partners New York $382M AUM 202.26% 1-Year Est. Return
RSS
Rosenblum Silverman Sutton San Francisco, California $382M AUM 13.82% 1-Year Est. Return
AC
Attestor Capital Grand Cayman, Cayman Islands $380M AUM

Weybosset Research & Management's Q4 2018 Portfolio in Review

As of Q4 2018, Weybosset Research & Management held 57 positions worth $147M, down 16% from $174M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Weybosset Research & Management's Q4 2018 filing shows 2 new, 16 increased, 29 reduced and 5 closed positions. Its largest new stake was AbbVie: 4,700 shares worth $433K. The largest sale was Ingredion, an estimated $930K.

By sector, the portfolio is most concentrated in Industrials at 32% of assets, up from 31% a quarter earlier, followed by Financials and Technology.

  • Weybosset Research & Management's largest Q4 2018 buy was AbbVie: 4,700 shares worth $433K.
  • Weybosset Research & Management added most to Welltower in Q4 2018, an estimated $197K increase.
  • Weybosset Research & Management's biggest Q4 2018 reduction was Ingredion, cutting an estimated $930K.
  • Weybosset Research & Management fully exited SLB Ltd in Q4 2018, selling an estimated $332K.
  • Weybosset Research & Management's ten largest holdings make up 54% of its $147M portfolio in Q4 2018.
  • Weybosset Research & Management opened 2 new positions and closed 5 in Q4 2018.
  • Weybosset Research & Management's portfolio value fell 16% quarter-over-quarter to $147M.

Based on Weybosset Research & Management's 13F filing for Q4 2018, filed 25 Jan 2019.